AMERIGEN PHARMACEUTICALS LTD. v. UCB PHARMA GMBH

2017-2596.

913 F.3d 1076 (2019)

AMERIGEN PHARMACEUTICALS LIMITED, Appellant v. UCB PHARMA GMBH, Appellee.

United States Court of Appeals, Federal Circuit.

Decided: January 11, 2019.


Attorney(s) appearing for the Case

WILLIAM HARE , McNeely Hare & War LLP, Princeton, NJ, argued for appellant. Also represented by SHYAM DIXIT , Dixit Law Firm, Tampa, FL.

JEFFREY J. OELKE , Fenwick & West, New York, NY, argued for appellee. Also represented by RYAN JOHNSON , LAURA MORAN , JAMES TRAINOR .

Before Lourie, Chen, and Stoll, Circuit Judges.


Amerigen Pharmaceuticals Limited ("Amerigen") appeals from the decision of the United States Patent and Trademark Office Patent Trial and Appeal Board (the "Board") in an inter partes review ("IPR") holding that claims 1-5 and 21-24 of U.S. Patent 6,858,650 (the "'650 patent") are not unpatentable as obvious. Mylan...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases